Investigational Site Number 826005

Bradford BD96RJ

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome, Hypercholesterolaemia

Studies at this site

• Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin) — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed